Special notice
Notice of Intent to Sole Source: Human Induced Pluripotent Stem Cell-derived Cells
CDRH-2024-122548
Food and Drug Administration, FDA Office of Acq Grant SVCS. In-Vitro Diagnostic Substance Manufacturing.
Awarded
Fujifilm Cellular Dynamics, Inc.
$26,680.00 obligated so far on USAspending
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one was awarded in 2024
13 like it are open now in in-vitro diagnostic substance manufacturing
- Reagents and consumables for Roche immunostainers
National Institutes of Health, National Institutes of Health Olao
Combined synopsis and solicitationNAICS 325413Anywhere in the US75N98027Q00026Closes in 14 daysNov 16 - NOI - DNA Sequencing of Bone Marrow Failure Syndro
National Institutes of Health, National Institutes of Health Olao
Combined synopsis and solicitationNAICS 325413Anywhere in the US75N98027Q00027Closes todayNov 2 - HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325413Anywhere in the US36C26227Q0046Closes todayNov 2
Description
As published on SAM.gov.
Please see attached document titled 'Notice of Intent to Sole Source_CDRH-2024-122548'.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Fujifilm Cellular Dynamics, Inc.
- UEI
- H1LMMSH2CRJ5
- CAGE
- 474X4
- Vendor location
- Madison, WI
- Contract
- 75F40124P00124, purchase order
- Obligated
- $26,680.00
- Actions
- 1 between May 8, 2024 and May 8, 2024
- Competition
- Not Competed Under SAP, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Human Induced Pluripotent Stem Cell-Derived Cells (Hipscs)
- Match
- solicitation number CDRH2024122548 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
March 18, 2024
Special notice
Due March 28, 2024 at 10:00 AM EDT. SAM.gov, notice 6538ee9b72724c36b7f83739b63cc814
Points of contact
- Benjamin Dorganbenjamin.dorgan@fda.hhs.gov